Tocilizumab-Induced Erythema Annulare Centrifugum

We report the case of a 42-year-old woman with rheumatoid arthritis undergoing treatment with subcutaneous tocilizumab for the past 6 months. Three days after the administration, an asymptomatic inflammatory annular plaque of 4 cm with discrete whitish scales at the inner border margin developed at...

Descripción completa

Detalles Bibliográficos
Autores principales: João, Ana Luísa, Pessoa e Costa, Tomás, Barreto, Paulo, Lencastre, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941759/
https://www.ncbi.nlm.nih.gov/pubmed/36824155
http://dx.doi.org/10.1159/000526938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941759/
https://www.ncbi.nlm.nih.gov/pubmed/36824155
http://dx.doi.org/10.1159/000526938

Ejemplares similares